Sometimes, you come across a new spot in the city and think, "This could be my new hideaway," a place to keep coming back to. For many, especially students and ...
US FDA grants rare paediatric designation to ARTHEx Biotech’s ATX-01 for the treatment of myotonic dystrophy type 1: Valencia, Spain Friday, November 8, 2024, 16:00 Hrs [IST] AR ...
Quoin Pharmaceuticals Ltd. (NASDAQ: QNRX) (the “Company” or “Quoin”), a clinical-stage, specialty pharmaceutical company focused on developing and commercializing novel treatments for rare and orphan ...
Becoming an Orlando Weekly Supporter for as little as $5 a month allows us to continue offering readers access to our coverage of local news, food, nightlife, events, and culture with no paywalls.
Acadia Pharmaceuticals said it is selling its rare pediatric disease priority review voucher for $150 million. The biotechnology company on Tuesday said it plans to invest the proceeds from the sale ...